How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Chemicals and Materials · Forecast 2027–2033
Bio Based Molecule Market
- By Source Material: Carbohydrates, Lipids, Proteins, Lignocellulosic Biomass, Algae
- By Product Type: Bio-based Acids, Bio-based Alcohols, Bio-based Amines, Bio-based Esters, Bio-based Polymers
- By Application: Pharmaceuticals, Food and Beverages, Cosmetics and Personal Care, Agriculture, Bioplastics
- By Production Technology: Fermentation, Enzymatic Conversion, Chemical Synthesis, Catalytic Conversion
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Carbohydrates leads By Source Material at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 281 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.168 →
- 11 Company Profiles 16 players: SWOT & benchmarking p.176 →
Full report · locked preview
Everything inside the Bio Based Molecule Market report
A complete, evidence-based study - 11 chapters and 118 sections covering market size, segmentation across 4 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Source Material 5
Product Type 5
Application 5
Production Technology 4
Companies profiled
BASF SE
DuPont de Nemours Inc.
Corbion N.V.
Cargill
Incorporated
Royal DSM N.V.
Evonik Industries AG
Genomatica Inc.
Novozymes A/S
LanzaTech Inc.
Amyris Inc.
Braskem S.A.
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →DuPont de Nemours Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Corbion N.V.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Cargill
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Royal DSM N.V.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Evonik Industries AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Genomatica Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Novozymes A/S
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →LanzaTech Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Amyris Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Braskem S.A.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Green Biologics Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Mitsubishi Chemical Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Solvay S.A.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Global Bioenergies
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,738M by 2033 · 8.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Carbohydrates34.1
- Lipids16.8
- Proteins14.6
- Lignocellulosic Biomass14.3
- Algae20.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$470.8M → $851.9M · 7.7%
Europe$328.2M → $571.2M · 7.2%
Asia Pacific$299.6M → $553.3M · 8.0%
Latin America$185.5M → $347.6M · 8.2%
Middle East and Africa$142.7M → $275.5M · 8.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.452026
8.452027
8.472028
8.472029
8.492030
8.502031
8.512032
8.532033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- BASF SE9.1
- DuPont de Nemours Inc.22.6
- Corbion N.V.10.3
- Cargill6.6
- Incorporated12.7
- Royal DSM N.V.10.6
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Source Material30.1%
Product Type28.0%
Application15.4%
Production Technology26.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.8
- Europe22.0
- Asia Pacific21.3
- Latin America13.4
- Middle East and Africa10.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| BASF SE | 77 | 90 | 96 | 84 | 85 | 98 | 88 |
| DuPont de Nemours Inc. | 84 | 85 | 89 | 68 | 69 | 78 | 79 |
| Corbion N.V. | 78 | 82 | 69 | 79 | 87 | 83 | 80 |
| Cargill | 69 | 65 | 80 | 64 | 77 | 66 | 70 |
| Incorporated | 75 | 77 | 56 | 72 | 57 | 66 | 67 |
| Royal DSM N.V. | 47 | 61 | 60 | 48 | 53 | 67 | 56 |
| Evonik Industries AG | 40 | 46 | 47 | 52 | 56 | 46 | 48 |
| Genomatica Inc. | 42 | 50 | 38 | 39 | 48 | 58 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- BASF SE
- DuPont de Nemours Inc.
- Corbion N.V.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| BASF SE | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| DuPont de Nemours Inc. | ◐ | ◐ | ✓ | ◐ | − | ◐ |
| Corbion N.V. | ✓ | ◐ | ✓ | ◐ | ✓ | ◐ |
| Cargill | ◐ | ✓ | ✓ | ✓ | ◐ | ◐ |
| Incorporated | ◐ | ◐ | − | ✓ | ◐ | ◐ |
| Royal DSM N.V. | − | ◐ | ◐ | − | ◐ | ◐ |
| Evonik Industries AG | − | − | − | − | − | − |
| Genomatica Inc. | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1BASF SE88
2Corbion N.V.80
3DuPont de Nemours Inc.79
4Cargill70
5Incorporated67
6Royal DSM N.V.56
7Evonik Industries AG48
8Genomatica Inc.46
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
BASF SEDuPont de Nemours Inc.Corbion N.V.
Challenger2
Strong scale, closing on the leaders.
CargillIncorporated
Niche3
Specialists in a single segment or region.
Royal DSM N.V.Evonik Industries AGGenomatica Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Source Material in North America, then scale across Bio Based Molecule Market — a $160M beachhead inside a $2.54B market.
Beachhead (SOM)$160Mobtainable near-term
Serviceable (SAM)$1.01Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Carbohydrates
Best fit — highest urgency & budget in Source Material.
Economic buyer81 fit
Lipids
Strong fit — clear ROI and a fast path to value.
End user69 fit
Proteins
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Source Material in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Product Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel28%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Source Material leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Bio Based Molecule Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified21%
Evaluation13%
Closed-won7%
$21.4KCAC
$73KLTV
3.4:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Bio Based Molecule Market is a durable-growth opportunity — $9.21B by 2033, compounding at 6.5%.
TAM · 2025$5.57Btoday
TAM · 2033$9.21Bforecast
CAGR6.5%2027–2033
Cumulative$65.3Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$9.21BTotal addressable market
SAM$3.35BServiceable available market
SOM$676MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.5% CAGR
Demand compounds through 2033, outpacing GDP across Source Material.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Source Material moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$9.21BLarge & growingTAM by 2033 at 6.5% CAGR
$3.35BServiceable nowreachable with today’s model
$676MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$7.18BBear4.2% CAGR
$9.21BBase6.5% CAGR
$11.8BBull8.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Product Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Bio Based Molecule Market — a $3.92B market by 2033. Plan: grow share from 8.3% to 15.5%.
Market size · 2033$3.92Btotal addressable
Market CAGR11.3%2027–2033
Target share15.5%from 8.3% today
Revenue ambition$608Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.3% | 15.5% | On track |
| Revenue | $355M | $608M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Ahead |
| Gross margin | 30.8% | 40.5% | On track |
| Customer retention | 87.8% | 96.1% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Source Material
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Product Type capability
A defensible second engine — invest in Product Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Source Material share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Product Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $65M capacity & capability investment
- Greenlight bolt-on M&A in Product Type
- Authorise North America expansion plan
- Fund R&D program for Source Material leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAhead
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Bio Based Molecule Market conversation — a $6.23B market you can size, segment and defend in minutes.
Market size · 2033$6.23Btotal opportunity
Growth10.5%CAGR to 2033
Addressable buyers1,579+accounts in scope
Typical ROI4.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Source Material
Goal Grow share in Source Material
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.4×return on cost, year one
< 3 mopayback period
$95K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
BASF SEDuPont de Nemours Inc.Corbion N.V.CargillIncorporatedRoyal DSM N.V.Evonik Industries AGGenomatica Inc.+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Bio Based Molecule Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Bio Based Molecule Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Chemicals and Materials · scroll →Bio-based Microbead Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportBio-based Methanol Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportBio-based Membrane Material BOPLA Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportBio-Based Matting Agent Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportBio-based Materials Market
Market size, share, segmentation and regional forecast.
$728M market · 2025 base year
View reportBio-based Malonic Acid Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportPneumatic Butterfly Valve Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportBiobased L-Valine Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportBiobased Long Chain Dicarboxylic Acid Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportBio-Based Limonene Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportBio-based Levulinic Acid Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportBiobased Lactide Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.